Clinical safety and efficacy of red blood cell Components treated with the s-303 pathogen inactivation system a randomized controlled double-blind phase 3 study in patients requiring transfusion support of acute anemia

DRK Blutspendedienst Baden-Wurttemberg – Hessen gGmbH, Frankfurt, Germany; Department of Thoracic and Cardiovascular Surgery, J. W. Goethe University, Frankfurt, Germany; Department of Haemostaseology and Transfusion Medicine, Bad Nauheim, Germany; German Red Cross Blood Donor Service Baden-Wuerttemberg- Hessen, Frankfurt, Germany; University Clinic Munich, Department for Transfusion Medicine, Munich, Germany; Cerus Corporation, Concord, United States of America

Vox Sanguinis. 2015;109((Suppl. 1)):28.. Abstract No. 3C-S10-04.
Study details